ACS Journal Cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ACS Journal Cancer
May 18, 2024, 10:12 |
Blog
Cancer disparities among sexual minority populations - ACS Journal Cancer
ACS Journal Cancer shared on their X/Twitter: ''A new study led by Aimee Huang et…
May 14, 2024, 16:28 |
Blog
Christian Rolfo: Great editorial by Ticiana Batista and Suresh S. Ramalingam on 20 years of EGFR
Christian Rolfo, Associate Director Clinical Research Center of Thoracic Oncology at The Tisch Cancer Institute…
May 13, 2024, 06:09 |
Blog
ACS Journal Cancer - Top advances of the year: Perioperative therapy for lung cancer
ACS Journal Cancer shared a post on X: "Top advances of the year: Perioperative therapy for…
May 7, 2024, 11:02 |
Insight
Cathy Eng: Important issues for our young adult cancer patients
Cathy Eng shared a post by ACS News on X/Twitter: "Such important issues for our young…
Apr 22, 2024, 11:52 |
Insight
Kelley C. Wood: What's important to older adults receiving chemotherapy?
Kelley C. Wood, Research Director at ReVital Cancer Rehab, shared a post by Enrique Soto…
Apr 19, 2024, 20:20 |
Drugs
This new review article is all about Tagraxofusp for BPDCN - ACS Journal Cancer
ACS Journal Cancer recently shared on X: "This new review article from Wei Ying Jen,…
Apr 19, 2024, 18:19 |
Insight
Enrique Soto: Our manuscript on the priorities of older patients regarding outcomes in cancer care is out in Journal Cancer
Enrique Soto shared a post on X: "Our manuscript on the priorities of older patients regarding…
Apr 7, 2024, 11:45 |
Drugs
Yüksel Ürün: Adding immunotherapy to cabozantinib for mccRCC after 1st line immunotherapy showed no extra benefit in real-world data
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post…
Apr 4, 2024, 20:02 |
Drugs
Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Apr 4, 2024, 13:47 |
Insight
Sumanta K. Pal: Excellent real world confirmation of our observations in CONTACT03
Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared…
1
2
All:
17
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube